DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells

By B. Tassaneetrithep, T. Burgess, A. Granelli‐Piperno, C. Trumpfheller, J. Finke, Wellington Sun, M. Eller, K. Pattanapanyasat, S. Sarasombath, D. Birx and 3 more. Journal of Experimental Medicine, 2003

909 citations recorded by the source corpus.

Dengue virus is a single-stranded, enveloped RNA virus that productively infects human dendritic cells (DCs) primarily at the immature stage of their differentiation. We now find that all four serotypes of dengue use DC-SIGN (CD209), a C-type lectin, to infect dendritic cells. THP-1 cells become susceptible to dengue infection after transfection of DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN), or its homologue L-SIGN, whereas the infection of dendritic cells is blocked by anti–DC-SIGN antibodies and not by antibodies to other molecules on these cells. Viruses produced by dendritic cells are infectious for DC-SIGN– and L-SIGN–bearing THP-1 cells and other permissive cell lines. Therefore, DC-SIGN may be considered as a new target for designing therapies that block dengue infection.

Subfields: Infectious Diseases, Public Health, Environmental and Occupational Health, Virology

View Paper: https://www.semanticscholar.org/paper/ac588cbbbe8105bdf14b497584292dbf8cc9c67c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

  1. S. Harrison

In Public Health, Environmental and Occupational Health

  1. S. Harrison

In Virology

  1. S. Harrison

Citations in the corpus